{"id":"W4410611436","doi":"10.1016/j.esmoop.2025.105110","title":"Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Bayer (Canada)","funders":"National Cancer Institute; Loxo Oncology; Bayer HealthCare; Bayer Corporation; Bayer","keywords":"Trk receptor; Cancer; Line (geometry); Fusion; Medicine; Internal medicine; Neurotrophin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002822551,0.00009186599,0.0002193094,0.00003728562,0.0001070071,0.0000118352,0.00004263408,0.00002866834,0.0001257846],"category_scores_gemma":[0.00002057796,0.00005669785,0.00002495896,0.00009700385,0.00002272736,0.00004493018,0.00003385861,0.00002091176,0.000001411591],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001324869,"about_ca_system_score_gemma":0.0001926506,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004260333,"about_ca_topic_score_gemma":0.001659849,"domain_scores_codex":[0.9995363,0.000007757365,0.0001291887,0.0001737313,0.00006280348,0.00009024688],"domain_scores_gemma":[0.9995983,0.00007534536,0.00005346215,0.0001422782,0.00008574287,0.00004489809],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01659906,0.003702368,0.6008496,0.0002161857,0.001854899,0.000005577612,0.00202542,0.00008494666,0.00001928678,0.0007883887,0.002452275,0.371402],"study_design_scores_gemma":[0.04678193,0.004152861,0.8062848,0.0006804101,0.001069385,9.677403e-7,0.00007544488,0.00002686621,0.001328726,0.00009513212,0.1394022,0.0001012421],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.981012,0.000215137,0.00007450717,0.002653761,0.0001144561,0.004296499,0.000136614,0.00001375305,0.01148324],"genre_scores_gemma":[0.9884914,0.0002899019,0.0007972086,0.0002077875,0.00002239063,0.0005082396,0.0001845648,0.0000112848,0.009487287],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3713007,"threshold_uncertainty_score":0.6440377,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01762276124513903,"score_gpt":0.3755784067848174,"score_spread":0.3579556455396784,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}